CAS: 947687-02-7 - (4S)-4,8,11-Triethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-9-yl [1,4′-bipiperidine]-1′-carboxylate
Fórmula:C35H42N4O6
InChI:InChI=1S/C35H42N4O6/c1-4-21-16-28-24(17-30(21)45-34(42)38-14-10-22(11-15-38)37-12-8-7-9-13-37)23(5-2)25-19-39-29(31(25)36-28)18-27-26(32(39)40)20-44-33(41)35(27,43)6-3/h16-18,22,43H,4-15,19-20H2,1-3H3/t35-/m0/s1
Clave InChI:InChIKey=IEKWXGPJFJGZSM-DHUJRADRSA-N
SMILES:O=C(OC1=CC=2C(=NC=3C4=CC5=C(C(=O)N4CC3C2CC)COC(=O)C5(O)CC)C=C1CC)N6CCC(N7CCCCC7)CC6
- Sinónimos:
- [1,4′-Bipiperidine]-1′-carboxylic acid, (4S)-4,8,11-triethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-9-yl ester
- (4S)-4,8,11-Triethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-9-yl [1,4′-bipiperidine]-1′-carboxylate
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
8-Ethyl Irinotecan REF: IN-DA01CB74CAS: 947687-02-7 | 95% | A consultar | Mar 26 Nov 24 | |
Irinotecan EP Impurity C REF: 4Z-I-187CAS: 947687-02-7 | - - - | A consultar | Mié 27 Nov 24 | |
8-Ethyl Irinotecan REF: TR-E921100CAS: 947687-02-7 | - - - | 458,00 €~5.328,00 € | Mar 10 Dic 24 | |
8-Ethyl irinotecan REF: 3D-XMB68702CAS: 947687-02-7 | Min. 95% | - - - | Producto descatalogado |
8-Ethyl Irinotecan
Ref: IN-DA01CB74
25mg | A consultar |
Irinotecan EP Impurity C
Ref: 4Z-I-187
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
8-Ethyl Irinotecan
Producto controladoRef: TR-E921100
1mg | 458,00 € | ||
5mg | 1.426,00 € | ||
25mg | 5.328,00 € |
8-Ethyl irinotecan
Ref: 3D-XMB68702
1mg | Descatalogado | Solicitar información | |
5mg | Descatalogado | Solicitar información | |
10mg | Descatalogado | Solicitar información | |
25mg | Descatalogado | Solicitar información |